Related Experiment Video
Updated: Nov 17, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea
Yan-Dong Li1, Bao-Ning Liu2, Si-Hai Zhao1
1Laboratory Animal Center, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.
Post-cholecystectomy diarrhea (PCD) is linked to gut dysbiosis, characterized by reduced microbial diversity and altered bacterial composition. These findings suggest new therapeutic avenues for managing PCD after gallbladder removal.
Area of Science:
- Gastroenterology
- Microbiome research
- Molecular biology
Background:
- Post-cholecystectomy diarrhea (PCD) is a common and challenging condition following gallbladder removal.
- Changes in bile acid-host-microbe interactions are implicated in PCD.
- The specific role of gut microbiota in PCD remains poorly understood.
Purpose of the Study:
- To investigate the relationship between gut microbiota and PCD.
- To characterize microbial community differences in patients with and without PCD.
Main Methods:
- Fecal DNA was analyzed using 16S rRNA gene sequencing.
- Gut microbiota composition and diversity were compared between healthy controls (HC), post-cholecystectomy non-diarrhea (PCND) patients, and PCD patients.
- Operational taxonomic units (OTUs), beta-diversity, and specific taxa abundances were quantified.
Main Results:
- The post-cholecystectomy (PC) group exhibited reduced microbial diversity and richness compared to HC.
- PCD patients showed decreased microbial diversity, a lower Firmicutes/Bacteroidetes ratio, and reduced levels of beneficial bacteria (Bifidobacterium, Lactococcus).
- Detrimental bacteria (Prevotella, Sutterella) were increased in PCD patients, with lower abundance of microbes involved in lipid metabolism.
Conclusions:
- Gut dysbiosis is strongly associated with PCD.
- Alterations in specific bacterial groups and metabolic pathways contribute to PCD pathogenesis.
- These findings offer novel therapeutic targets for PCD management.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

